Related Experiment Videos
Impact of contrast echocardiography on diagnostic algorithms: pharmacoeconomic implications
1Cardiovascular Health Services Research, Emory University, Atlanta, Georgia 30322, USA.
Insights
Myocardial contrast echocardiography enhances diagnostic accuracy and cost-effectiveness in cardiology. This advanced technique improves imaging quality, reducing repeat testing and ensuring better patient care within managed care settings.
Area of Science:
- Cardiology
- Medical Imaging
- Health Economics
Background:
- Managed care emphasizes cost control and high-quality healthcare.
- Routine echocardiography is cost-effective but can be suboptimal, especially in certain patient groups.
- Myocardial contrast echocardiography offers potential improvements over standard echocardiography.
Purpose of the Study:
- To evaluate the impact of myocardial contrast echocardiography on diagnostic accuracy and cost-effectiveness.
- To assess the role of contrast agents in improving echocardiogram quality and interpretation.
- To determine if enhanced echocardiography can reduce downstream testing and improve patient care patterns.
Main Methods:
- Review of phase II and III studies on myocardial contrast echocardiography.
- Analysis of contrast agent's effect on endocardial border delineation, left ventricular opacification, and Doppler signal.
- Comparison of diagnostic accuracy and cost-effectiveness with standard echocardiography and other noninvasive modalities like SPECT imaging.
Main Results:
- Contrast agents significantly improve the diagnostic accuracy of echocardiography.
- Enhanced image quality reduces suboptimal echocardiograms, particularly in obese patients and those with lung disease.
- Improved accuracy impacts downstream testing, potentially increasing throughput and reducing false positives/negatives.
Conclusions:
- Myocardial contrast echocardiography offers improved diagnostic capabilities.
- Its use in selected patients leads to enhanced accuracy and cost-effective care.
- This technique aligns with the goals of managed care by optimizing technology use and patient outcomes.
Abstract:
The major goal of medicine in the era of managed care is to control escalating costs and to attain a high level of quality health care. Capitation has limited access to expensive and unnecessary testing, placing an emphasis on the prudent use of available technology. A vast armamentarium of available diagnostic screening tests are available within cardiology. Routine two-dimensional (2-D) echocardiography is a high-quality, low-cost test that provides enhanced portability and real-time test interpretation over other noninvasive test modalities. The echocardiogram may cost up to 50% less than competitive nuclear single-photon emission computed tomography (SPECT) imaging. However, on average 10% of routine and 33% of stress echocardiograms are suboptimal (disproportionately affecting obese patients and those with lung disease). Myocardial contrast echocardiography has been shown to provide enhanced endocardial border delineation and left ventricular opacification, to enhance Doppler signal, and to provide information on myocardial perfusion. In several recent phase II and III studies, the use of a contrast agent has been shown to improve the diagnostic accuracy of echocardiography substantially. Improvements in the diagnostic capabilities of echocardiography have been shown to (1) impact upon downstream repetitive testing in patients with an initially nondiagnostic echocardiogram, (2) potentially increase laboratory throughput, and (3) reduce the rate of false-positive and negative tests as a result of improved image quality. As clinical and cost-effectiveness parallel one another, the use of myocardial contrast echocardiography in selected patient cohorts will result in improved diagnostic accuracy and a cost-effective pattern of care.